EyePoint, Inc.
EYPT
Jodie situation report
EyePoint, Inc.'s current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 26 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 1 directly disclosed connection is confirming.
- EYPT's market-adjusted activity becomes unusual and at least one connected name confirms.
Invalidation: The isolated read changes if EYPT's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind EYPT
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depended on by
FDMT4D Molecular Therapeutics, Inc.competitorMar 18, 2026 ▾
“We also face competition from late-stage sustained release VEGF receptor tyrosine kinase 11 inhibitor programs at EyePoint Inc.”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 7 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
EYPT is currently a Follower in the organic co-movement group Industrial & Healthcare Solutions. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 1 filing-linked name are in the relationship map; none is currently confirmed as moving with the group.
This group is retained as the last observed read for EYPT; it is not active in the latest market snapshot.